Correlation Between Dogwood Therapeutics, and AptarGroup
Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and AptarGroup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and AptarGroup into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dogwood Therapeutics, and AptarGroup, you can compare the effects of market volatilities on Dogwood Therapeutics, and AptarGroup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of AptarGroup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and AptarGroup.
Diversification Opportunities for Dogwood Therapeutics, and AptarGroup
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Dogwood and AptarGroup is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and AptarGroup in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptarGroup and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with AptarGroup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptarGroup has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and AptarGroup go up and down completely randomly.
Pair Corralation between Dogwood Therapeutics, and AptarGroup
Given the investment horizon of 90 days Dogwood Therapeutics, is expected to under-perform the AptarGroup. In addition to that, Dogwood Therapeutics, is 9.81 times more volatile than AptarGroup. It trades about -0.06 of its total potential returns per unit of risk. AptarGroup is currently generating about -0.12 per unit of volatility. If you would invest 16,910 in AptarGroup on September 26, 2024 and sell it today you would lose (975.00) from holding AptarGroup or give up 5.77% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dogwood Therapeutics, vs. AptarGroup
Performance |
Timeline |
Dogwood Therapeutics, |
AptarGroup |
Dogwood Therapeutics, and AptarGroup Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dogwood Therapeutics, and AptarGroup
The main advantage of trading using opposite Dogwood Therapeutics, and AptarGroup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, AptarGroup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptarGroup will offset losses from the drop in AptarGroup's long position.Dogwood Therapeutics, vs. Eupraxia Pharmaceuticals Common | Dogwood Therapeutics, vs. Opus Genetics, | Dogwood Therapeutics, vs. Telix Pharmaceuticals Limited |
AptarGroup vs. Haemonetics | AptarGroup vs. Merit Medical Systems | AptarGroup vs. AngioDynamics | AptarGroup vs. Envista Holdings Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |